CanSino Biologics (06185.HK) announced its first quarter financial results, with a net loss attributable to owners of approximately 11.54 million yuan, a decrease of 93.21% year-on-year.

Intelligence Financial News App, CanSino Biologics (06185.HK) announced its performance for the first quarter of 2025, with operating income of approximately 137 million yuan, an increase of 20.02% year-on-year; net loss attributable to shareholders of the listed company was approximately 11.5454 million yuan, a decrease of 93.21% year-on-year. Basic loss per share was 0.05 yuan.